NBY

NovaBay Pharmaceuticals Inc New
1.54
0.05 (3.36%)

NovaBay Pharmaceuticals Inc. (NBY) Fundamentals

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
SHARE INFORMATION
Market Cap$ 2,795,902
Shares Outstanding1,876,444
Float1,852,931
Percent Float98.75%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 8,421,000
Latest Fiscal EPS$ -5.25
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions40
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months10,612
Institutional Holdings Percent11.6%
Institutional Sold Previous 3 Months61,539
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent3.4
Insider Sold Previous 3 Months23,842
Insider Shares Owned2,220,374
TRADING INFO
52 Week High$ 12.64
52 Week Low$ 1.24
52 Week High Change$ -86.56
21 Day Moving Average$ 1.8407
21 Day Extended Moving Average$ 1.763
50 Day Moving Average$ 2.0929
50 Day Extended Moving Average$ 2.0077
200 Day Moving Average$ 4.6161
200 Day Extended Moving Average$ 4.6417
10 Day Average Volume17,824
20 Day Average Volume14,328
30 Day Average Volume14,313
50 Day Average Volume29,529
Alpha-0.021644
Beta2.7745
Standard Deviation0.479836
R20.096956
7 Day Price Change$ -0.09
7 Day Percent Change-5.7%
21 Day Price Change$ -0.71
21 Day Percent Change-32.27%
30 Day Price Change$ -0.68
30 Day Percent Change-31.34%
Month to Date Price Change$ -0.81
Month to Date Percent Change-35.22%
Quarter to Date Price Change$ -0.46
Quarter to Date Percent Change-23.59%
180 Day Price Change$ -2.36
180 Day Percent Change-61.3%
200 Day Price Change$ -6.61
200 Day Percent Change-81.61%
Year to Date Price Change$ -0.46
Year to Date Percent Change-23.59%

NovaBay Pharmaceuticals Inc. (NBY) Key Ratios

PROFITABILITY
EBIT Margin-67.4%
EBITDA Margin-63.7%
Pre-Tax Profit Margin-64.3%
Profit Margin Count-22.32%
Gross Margin56.2%
Profit Margin TOT-22.32%
INCOME STATEMENTS
Revenue$ 10,761,000
Revenue Per Share$ 5.7348
Revenue (3 Years)$ 13.39
Revenue (5 Years)$ -10.99
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio2.90
Leverage Ratio1.50
Quick Ratio1.60
Long Term Debt To Capital0.11
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ 1,674,666
Price to Sales0.259818
Price to Free Cash-0.50
PE High Last 5 Years-2.80
Price To Book0.20
Price To Cash Flow0.00
PE Low Last 5 Years-1.50
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.00
Invoice Turnover1.60
Assets Turnover0.50
Return Assets-54.68
Return on Equity-84.67
Return on Capital-71.81

NovaBay Pharmaceuticals Inc. (NBY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorWithumSmith+Brown, PC
CEOJustin M. Hall
Emplyoees31
Last AuditUE
CIK0001389545
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address2000 Powell Street
Suite 1150
Emeryville, CA 94608
Websitehttps://www.novabay.com
Facsimile+1 510 474-1577
Telephone+1 510 899-8800
Emailjhall@novabay.com


Your Recent History
AMEX
NBY
NovaBay Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.